United States Biotechnology & Medical Research

Absci Corp (ABSI)

Absci Corp has seen no insider activity within the last three months. The most recent recorded transaction occurred on June 30, 2026, involving a purchase. Prior to this period, various executives and entities engaged in multiple buying and selling actions throughout early 2026 and late 2025.
Ticker: ABSI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Absci Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Szela Mary T Non-Executive Director
Transaction date
Purchase
Price
318.75
Quantity 35,244 +35.5%
Value US$3,949,896
4.1
Pangalos Menelas N Non-Executive Director
Transaction date
Purchase
Price
407.46
Quantity 32,307 -23.3%
Value US$3,205,483
4.2
Busch Andreas Chief Innovation Officer Officer
Transaction date
Purchase
Price
46.60
Quantity 99,992 +47.1%
Value US$4,984,887
4.1
Pangalos Menelas N Non-Executive Director
Transaction date
Purchase
Price
2.74
Quantity 75,095 +65.9%
Value US$205,760
2.6
Jonasson Zachariah CFO / CBO Officer
Transaction date
Sale
Price
2.99
Quantity 17,496 -4.4%
Value US$52,313
1.5
McClain Sean Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.99
Quantity 26,761 -0.3%
Value US$80,015
1.3
VAN HOUTEN FRANS Non-Executive Director
Transaction date
Purchase
Price
3.72
Quantity 40,000 +171.5%
Value US$148,800
4.1
Pangalos Menelas N Non-Executive Director
Transaction date
Purchase
Price
2.66
Quantity 95,785 +527.0%
Value US$254,788
3.3
Bedrick Todd SVP, CAO Officer
Transaction date
Purchase
Price
2.70
Quantity 10,000 +5.9%
Value US$27,000
4.2
Busch Andreas Chief Innovation Officer Officer
Transaction date
Purchase
Price
3.04
Quantity 50,000 +18.0%
Value US$152,000
2.6
Jonasson Zachariah CFO / CBO Officer
Transaction date
Sale
Price
4.98
Quantity 19,859 -4.9%
Value US$98,892
2.6
ZACHARIAH JONASSON Officer Officer
Transaction date
Proposed sale
Price
4.98
Quantity 19,859
Value US$98,892
3.2
Redmile Group, LLC Non-Executive Director
Transaction date
Purchase
Price
4.50
Quantity 222,222 +2.8%
Value US$999,999
1.4
Korman Sarah General Counsel Officer
Transaction date
Purchase
Price
7.96
Quantity 4,250 +42.5%
Value US$33,830
3.3
Bedrick Todd VP, CCPAO Officer
Transaction date
Purchase
Price
7.50
Quantity 2,000 +200.0%
Value US$15,000
1.5
McClain Sean President and Chief Executive Executive Director
Transaction date
Purchase
Price
6.92
Quantity 7,155 +0.1%
Value US$49,513
1.4
Korman Sarah General Counsel Officer
Transaction date
Purchase
Price
16.00
Quantity 10,000 New position
Value US$160,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-06 2026-06-30 B Purchase
2.2
Szela Mary T
Non-Executive Director
35,244 +35.5%
318.75
US$3,949,896 		35,244 +35.5% 318.75 US$3,949,896
2026-05-13 2026-05-13 B Purchase
4.1
Pangalos Menelas N
Non-Executive Director
32,307 -23.3%
407.46
US$3,205,483 		32,307 -23.3% 407.46 US$3,205,483
2026-03-16 2026-03-12 B Purchase
4.2
Busch Andreas

Chief Innovation Officer

Officer
99,992 +47.1%
46.60
US$4,984,887 		99,992 +47.1% 46.60 US$4,984,887
2026-03-03 2026-02-27 B Purchase
4.1
Pangalos Menelas N
Non-Executive Director
75,095 +65.9%
2.74
US$205,760 		75,095 +65.9% 2.74 US$205,760
2026-02-04 2026-02-02 S Sale
2.6
Jonasson Zachariah

CFO / CBO

Officer
17,496 -4.4%
2.99
US$52,313 		17,496 -4.4% 2.99 US$52,313
2026-02-04 2026-02-02 S Sale
1.5
McClain Sean

Chief Executive Officer

Executive Director
26,761 -0.3%
2.99
US$80,015 		26,761 -0.3% 2.99 US$80,015
2025-12-09 2025-12-05 B Purchase
1.3
VAN HOUTEN FRANS
Non-Executive Director
40,000 +171.5%
3.72
US$148,800 		40,000 +171.5% 3.72 US$148,800
2025-09-24 2025-09-22 B Purchase
4.1
Pangalos Menelas N
Non-Executive Director
95,785 +527.0%
2.66
US$254,788 		95,785 +527.0% 2.66 US$254,788
2025-09-24 2025-09-22 B Purchase
3.3
Bedrick Todd

SVP, CAO

Officer
10,000 +5.9%
2.70
US$27,000 		10,000 +5.9% 2.70 US$27,000
2025-07-29 2025-07-28 B Purchase
4.2
Busch Andreas

Chief Innovation Officer

Officer
50,000 +18.0%
3.04
US$152,000 		50,000 +18.0% 3.04 US$152,000
2024-06-14 2024-06-13 S Sale
2.6
Jonasson Zachariah

CFO / CBO

Officer
19,859 -4.9%
4.98
US$98,892 		19,859 -4.9% 4.98 US$98,892
2024-06-13 2024-06-13 PrS Proposed sale
2.6
ZACHARIAH JONASSON

Officer

Officer
19,859
4.98
US$98,892 		19,859 4.98 US$98,892
2024-05-28 2024-05-22 S Sale
2.9
Phoenix Venture Partners II LP
Large shareholder
3,100,000 -21.6%
4.40
US$13,640,000 		3,100,000 -21.6% 4.40 US$13,640,000
2024-03-05 2024-03-01 B Purchase
3.2
Redmile Group, LLC
Non-Executive Director
222,222 +2.8%
4.50
US$999,999 		222,222 +2.8% 4.50 US$999,999
2022-02-10 2022-02-09 B Purchase
1.4
Korman Sarah

General Counsel

Officer
4,250 +42.5%
7.96
US$33,830 		4,250 +42.5% 7.96 US$33,830
2022-01-24 2022-01-20 B Purchase
3.3
Bedrick Todd

VP, CCPAO

Officer
2,000 +200.0%
7.50
US$15,000 		2,000 +200.0% 7.50 US$15,000
2022-01-19 2022-01-19 B Purchase
1.5
McClain Sean

President and Chief Executive

Executive Director
7,155 +0.1%
6.92
US$49,513 		7,155 +0.1% 6.92 US$49,513
2021-07-28 2021-07-26 B Purchase
1.4
Korman Sarah

General Counsel

Officer
10,000 New position
16.00
US$160,000 		10,000 New position 16.00 US$160,000
2021-07-28 2021-07-26 B Purchase
3.1
Casdin Partners Master Fund, L.P.
Non-Executive Director
1,562,500 +30.1%
16.00
US$25,000,000 		1,562,500 +30.1% 16.00 US$25,000,000
Explore more

More insider trading research around Absci Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America